21 March 2023 DHPC (direct to healthcare professional communication) letter regarding pholcodine Pholcodine-containing medicinal products are no longer available on the UK market Following a review by the Medicines and Healthcare products... MHRA logo
15 March 2023 Spring Budget 2023, PAGB comment Today’s Budget announcement included confirmation that the Medicines and Healthcare products Regulatory Agency (MHRA) will receive £10 million extra funding... Spring Budget 2023, PAGB comment
14 March 2023 MHRA’s precautionary decision on pholcodine-containing medicinal products Following a review by the Medicines and Healthcare products Regulatory Agency (MHRA), the UK regulator has taken the precautionary step... MHRA logo
2 March 2023 ASA rejects ‘vaping to quit smoking’ claims A recent ASA ruling highlighted the risks of making smoking cessation claims for products without a relevant MHRA licence. An... ASA rejects ‘vaping to quit smoking’ claims
27 February 2023 PAGB welcomes “very positive outcome” securing supply of medicines for Northern Ireland and UK PAGB welcomes today’s announcement and the positive outcome of these negotiations. We have always said that it is important that... PAGB welcomes “very positive outcome” securing supply of medicines for Northern Ireland and UK
23 February 2023 PAGB statement on the review of pseudoephedrine Available for over 40 years and with a well-established safety profile, pseudoephedrine is an active ingredient which is used as... PAGB statement on the review of pseudoephedrine
20 February 2023 Mail on Sunday coverage of over-the-counter medicines supply Michelle Riddalls, Chief Executive of PAGB, the consumer healthcare association, which represents the manufacturers of over-the counter-medicines (OTC)... Mail on Sunday coverage of over-the-counter medicines supply
15 February 2023 CAP guidance on environmental claims: ‘carbon neutral’ and ‘net zero’ claims The ASA has published updated guidance on environmental claims in advertising, advising marketers to avoid using unqualified carbon neutral, net... CAP guidance on environmental claims: ‘carbon neutral’ and ‘net zero’ claims
14 February 2023 PAGB response to the BBC’s coverage of salt levels in soluble OTC medicines Michelle Riddalls, PAGB Chief Executive: “The comparison by the Morning Live programme of salt content in soluble products, versus... PAGB response to the BBC’s coverage of salt levels in soluble OTC medicines
2 February 2023 ASA ruling on using comparative nutrition claims A recent ASA ruling gives an example of what not to do when using these types of... ASA ruling on using comparative nutrition claims
26 January 2023 MailOnline article on salt levels in soluble OTC medicines, PAGB response PAGB response to MailOnline article on salt levels in soluble OTC medicinesMichelle Riddalls, PAGB Chief Executive: “The sodium in effervescent... MailOnline article on salt levels in soluble OTC medicines, PAGB response
18 January 2023 Cooperation and negotiation key to continuing a secure supply of medicines to Northern Ireland: PAGB CEO gives evidence to House of Lords Cooperation and negotiation key to continuing a secure supply of medicines to Northern Ireland: PAGB CEO gives evidence to House... Cooperation and negotiation key to continuing a secure supply of medicines to Northern Ireland: PAGB CEO gives evidence to House of Lords
